Compound Summary
lfm-a13
Compound Information
lfm-a13
Compound Name: | lfm-a13 |
Compound CID: | 54676905 |
Synonyms: | lfm-a13 244240-24-2 (Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide 62004-35-7 SMR001230714 More... |
Iupac Name: | (Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide |
InChI: | InChI=1S/C11H8Br2N2O2/c1-6(16)8(5-14)11(17)15-10-4-7(12)2-3-9(10)13/h2-4,16H,1H3,(H,15,17)/b8-6- |
InChIKey: | UVSVTDVJQAJIFG-VURMDHGXSA-N |
Canonical Smiles: | CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O |
Isomeric Smiles: | C/C(=C(\C#N)/C(=O)NC1=C(C=CC(=C1)Br)Br)/O |
Molecular Weight: | 360 |
Molecular Formula: | C11H8Br2N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
lfm-a13
Molecular Weight: | 360 |
Molecular Formula: | C11H8Br2N2O2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 17 |
Complexity: | 386 |
Synonyms
lfm-a13
| lfm-a13 | lfm-a13 |
|---|---|
lfm-a13 |
244240-24-2 |
(Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide |
62004-35-7 |
SMR001230714 |
alpha-Cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)propenamide |
SR-01000075965 |
C11H8Br2N2O2 |
BiomolKI_000050 |
BiomolKI2_000056 |
Lopac0_000650 |
SCHEMBL51142 |
BMK1-F2 |
BSPBio_001239 |
MLS002153290 |
MLS006010694 |
GTPL9262 |
LFM-A13(Z) |
CHEBI:95065 |
DTXSID101017390 |
HMS1362M21 |
HMS1792M21 |
HMS1990M21 |
HMS2235P16 |
HMS3403M21 |
HMS3414K07 |
HMS3678K07 |
BCP12817 |
3781AH |
s7734 |
ZINC37868487 |
AKOS024456516 |
CCG-100654 |
CS-3890 |
LP00650 |
SDCCGSBI-0050630.P002 |
IDI1_002205 |
NCGC00025100-02 |
NCGC00025100-03 |
NCGC00025100-04 |
NCGC00025100-05 |
NCGC00025100-06 |
NCGC00025100-07 |
NCGC00025100-08 |
NCGC00481569-01 |
HY-18009 |
LFM-A13, >=98% (HPLC), powder |
QC-11797 |
B5952 |
EU-0100650 |
K00067 |
L 8789 |
A877921 |
SR-01000075965-1 |
SR-01000075965-3 |
Q27080265 |
(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide |
a-Cyano-b-hydroxy-b-methyl-N-(2,5-dibromophenyl)propenamide |
(2Z)-2-CYANO-N-(2,5-DIBROMOPHENYL)-3-HYDROXY-2-BUTENAMIDE |
2-Butenamide,2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-, (2Z)- |
(Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide(LFM-A13) |
alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide |
LFMA13;LFM A13;(Z)-2-Cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide |
Experimental Data
lfm-a13
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 88.000000000000000 | umol/L | 27.000000000000000 | S | N2 | 24134630 | Active | ||||||
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 27.000000000000000 | S | N2 | 33683565 | Active |
Experimental Data Visualization
lfm-a13
Statistics Data
lfm-a13
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 27.000000000000000 | 2 | 2 |
Statistics Data Visualization
lfm-a13
